SCHEMBL7212435

SCHEMBL7212435

CNCC(O)c1cc(C(F)(F)F)nc2c(C(F)(F)F)cccc12

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 8/20 0.71
CYP3A4 P08684 4/20 0.62
CYP2D6 P10635 2/20 0.62
ADORA2A P29274 6/20 0.54
ADORA1 P30542 6/20 0.54
ADORA3 P0DMS8 2/20 0.54
HTR1A P08908 2/20 0.54
TSHR P16473 2/20 0.54
ADRA1A P35348 2/20 0.54
DRD3 P35462 2/20 0.54
SLC6A3 Q01959 2/20 0.54
KDM4E B2RXH2 2/20 0.54
LMNA P02545 2/20 0.54
ADORA2B P29275 1/20 0.54
CYP2C19 P33261 1/20 0.54
ABCG2 Q9UNQ0 1/20 0.54
NR1I2 O75469 1/20 0.54
TP53 P04637 1/20 0.54
CYP1A2 P05177 1/20 0.54
CNR1 P21554 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18343527 0.88 KCNH2 (0.68) KCNH2CYP3A4CYP2D6ADORA2AADORA1
SCHEMBL7208777 0.87 KCNH2 (0.73) KCNH2CYP3A4CYP2D6ADORA2AADORA1
SCHEMBL18343549 0.87 KCNH2 (0.73) KCNH2CYP3A4CYP2D6ADORA2AADORA1
SCHEMBL13017651 0.86 KCNH2 (0.72) KCNH2CYP3A4CYP2D6ADORA2AADORA1
SCHEMBL18343520 0.86 KCNH2 (0.78) KCNH2CYP3A4CYP2D6ADORA2AADORA1
SCHEMBL18343517 0.86 KCNH2 (0.86) KCNH2CYP3A4CYP2D6ADORA2AADORA1
SCHEMBL18343551 0.86 KCNH2 (0.78) KCNH2CYP3A4CYP2D6ADORA2AADORA1
SCHEMBL7213635 0.86 KCNH2 (0.66) KCNH2CYP3A4CYP2D6ADORA2AADORA1
SCHEMBL11928628 0.86 KCNH2 (0.65) KCNH2CYP3A4CYP2D6ADORA2AADORA1
SCHEMBL11904470 0.86 KCNH2 (0.65) KCNH2CYP3A4CYP2D6ADORA2AADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016209688-A1 COMPOSITIONS FOR THE TREATMENT OF CANCER AND USES THEREOF UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) 2016-12-29 WO disclosed
US-6608085-B1 Administering for neuroprotection VERNALIS RESEARCH LIMITED (GB) 2003-08-19 US disclosed
EP-1107761-A2 4-QUINOLINEMETHANOL DERIVATIVES AS PURINE RECEPTOR ANTAGONISTS (II) VERNALIS RESEARCH LIMITED (GB) 2001-06-20 EP disclosed
WO-2000013682-A2 4-QUINOLINEMETHANOL DERIVATIVES AS PURINE RECEPTOR ANTAGONISTS.(II) VERNALIS RESEARCH LIMITED (GB) 2000-03-16 WO disclosed